Publications by authors named "Aiming Yu"

Claim this Profile
S
Small RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions.
Joseph M Cronin, Ai-Ming Yu

Front Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circadian regulator REV-ERBα is a master regulator of tumor lineage plasticity and an effective therapeutic target.
Xiong Zhang, Yatian Yang, Hongye Zou, Demin Cai, Eva Corey, Ai-Ming Yu

Proc Natl Acad Sci U S A· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Pharmacokinetic-Pharmacodynamic Models in Oncology.
Su Guan, Mei-Juan Tu, Ai-Ming Yu

Pharmaceutics· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A reference-guided iterative approach to polish the nanopore sequencing basecalling for therapeutic RNA quality control.
Ziyuan Wang, Mei-Juan Tu, Ziyang Liu, Katherine K Wang, Yinshan Fang, Ai-Ming Yu

Commun Biol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Fermentation Production of RNA Interference Agents.
Neelu Batra, Mei-Juan Tu, Ai-Ming Yu

Methods Mol Biol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors.
Xiong Zhang, Yatian Yang, Hongye Zou, Yang Yang, Xingling Zheng, Ai-Ming Yu, Yuanpei Li

Acta Pharm Sin B· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioengineered miR-7-5p modulates non-small cell lung cancer cell metabolism to improve therapy.
Gavin M Traber, Mei-Juan Tu, Su Guan, Neelu Batra, Ai-Ming Yu

Mol Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2024 Nobel Prize in Physiology or Medicine: microRNA Takes Center Stage.
George A Calin, Florent Hubé, Michael R Ladomery, Nicholas Delihas, Manuela Ferracin, Ai-Ming Yu

Noncoding RNA· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells.
Zachary A Schaaf, Shu Ning, Amy R Leslie, Masuda Sharifi, Richard Y Gao, Ai-Ming Yu

Cancer Res Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Three Computational Tools for the Prediction of RNA Tertiary Structures.
Frank Yiyang Mao, Mei-Juan Tu, Gavin McAllister Traber, Ai-Ming Yu

Noncoding RNA· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Precise Basecalling of Short-Read Nanopore Sequencing.
Ziyuan Wang, Mei-Juan Tu, Chengcheng Song, Ziyang Liu, Katherine K Wang, Ai-Ming Yu

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Iterative Approach to Polish the Nanopore Sequencing Basecalling for Therapeutic RNA Quality Control.
Ziyuan Wang, Mei-Juan Tu, Ziyang Liu, Katherine K Wang, Yinshan Fang, Ai-Ming Yu

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs.
Yimei Wang, Mei-Juan Tu, Ai-Ming Yu

Front Pharmacol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Growing Class of Novel RNAi Therapeutics.
Gavin M Traber, Ai-Ming Yu

Mol Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Engineering of Functional SiRNA Agents.
Neelu Batra, Mei-Juan Tu, Ai-Ming Yu

ACS Synth Biol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents.
Gavin M Traber, Colleen Yi, Neelu Batra, Mei-Juan Tu, Ai-Ming Yu

RNA· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy.
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Chien-Yu Chen, Lu-Yuan Li, Ai-Ming Yu

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer.
Yixin Chen, Mei-Juan Tu, Fangwei Han, Zhenzhen Liu, Neelu Batra, Ai-Ming Yu

Acta Pharm Sin B· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances in Novel Recombinant RNAs for Studying Post-transcriptional Gene Regulation in Drug Metabolism and Disposition.
Mei-Juan Tu, Ai-Ming Yu

Curr Drug Metab· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Author correction to 'Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis ' [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965].
Linglong Deng, Hannah Petrek, Mei-Juan Tu, Neelu Batra, Ai-Xi Yu, Ai-Ming Yu

Acta Pharm Sin B· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research.
Joseph M Cronin, Ai-Ming Yu

Drug Metab Dispos· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Flux Analysis Reveals the Roles of Stearate and Oleate on CPT1C-mediated Tumor Cell Senescence.
Panpan Chen, Jingyu Tian, Yanying Zhou, Yixin Chen, Huizhen Zhang, Ai-Ming Yu

Int J Biol Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATR Inhibition in Advanced Urothelial Carcinoma.
Ryan C Leibrandt, Mei-Juan Tu, Ai-Ming Yu, Primo N Lara, Mamta Parikh

Clin Genitourin Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Post-transcriptional regulation and its misregulation: From molecular basis to translational medicine.
Ye Tian, Ai-Ming Yu, Chong Yin, Airong Qian

Front Cell Dev Biol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes.
Shu Ning, Jinge Zhao, Alan P Lombard, Leandro S D'Abronzo, Amy R Leslie, Aiming Yu

Commun Med (Lond)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis